Kevin Smith to Lead Business Development Efforts at Inogen

Inogen Inc. has appointed Kevin P. Smith as general counsel and executive vice president, Business Development, effective July 22. Smith (no relation to Inogen’s CEO) joins the company from Sirtex Medical, where he was general counsel and executive vice president, Business Development, since 2018.

Smith has nearly 30 years of experience. Before Sirtex, Smith was vice president and associate general counsel at Flexion Therapeutics, focusing on securities requirements, business development, and intellectual property. Previously, he was general counsel for the Danaher Life Sciences Platform. He has also held senior legal leadership positions within Novartis Pharmaceuticals. Before moving in-house, Smith worked for multinational law firms in New York, Silicon Valley, and London.

“Kevin will be an invaluable addition to our leadership team at Inogen,” Inogen President/CEO Kevin Smith stated. “His extensive experience in the medical device and securities field will play an important role in strengthening our legal team and ensuring Inogen remains an organization based on integrity and compliance.”

Inogen Inc. is a global medical technology company offering respiratory products for use in the homecare setting. Inogen supports patient respiratory care by developing, manufacturing, and marketing best-in-class portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. Inogen partners with patients, prescribers, home medical equipment providers, and distributors to make its oxygen therapy products widely available, giving patients the chance to remain ambulatory while managing their disease.